These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10600014)

  • 21. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.
    Doxiadis II; Smits JM; Schreuder GM; Persijn GG; van Houwelingen HC; van Rood JJ; Claas FH
    Lancet; 1996 Sep; 348(9031):850-3. PubMed ID: 8826810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation.
    Emonds MP; Herman J; Dendievel J; Waer M; Van Damme-Lombaerts R
    Pediatr Transplant; 2000 Feb; 4(1):6-11. PubMed ID: 10731052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.
    Dankers MK; Witvliet MD; Roelen DL; de Lange P; Korfage N; Persijn GG; Duquesnoy R; Doxiadis II; Claas FH
    Transplantation; 2004 Apr; 77(8):1236-9. PubMed ID: 15114091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of circulating antibodies in a renal transplantation population: preliminary results.
    Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F
    Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors.
    Sutherland DE; Morrow CE; Kaufman D; Fryd DS; Najarian JS; Burke M; Noreen H; Segall M; Bach FH
    Transplantation; 1983 Dec; 36(6):643-7. PubMed ID: 6362140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
    Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
    Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies.
    Fotheringham J; Angel C; Goodwin J; Harmer AW; McKane WS
    Transplantation; 2011 May; 91(9):991-6. PubMed ID: 21519315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens.
    van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; ten Berge IJ; Claas FH
    Transplantation; 2001 Apr; 71(7):869-74. PubMed ID: 11349718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C; Wettstein D; Döhler B; Morath C; Ruhenstroth A; Scherer S; Tran TH; Gombos P; Schemmer P; Wagner E; Fehr T; Živčić-Ćosić S; Balen S; Weimer R; Slavcev A; Bösmüller C; Norman DJ; Zeier M; Opelz G;
    Transplantation; 2015 Sep; 99(9):1976-80. PubMed ID: 25769065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience.
    Buscaroli A; De Sanctis LB; Iannelli S; Stipo L; Bertuzzi V; Raimondi C; Mosconi G; Liviano D' Arcangelo G; Scolari MP; Stefoni S
    Transpl Int; 2000; 13 Suppl 1():S99-105. PubMed ID: 11111973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.
    Silva E; Alba A; Castro A; Carrascal M; Buckel E; Aguiló J; Herzog C; Calabrán L; Morales J; Fierro JA
    Transplant Proc; 2010; 42(1):266-9. PubMed ID: 20172326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.